Abdullahi Tunde Aborode , Ayomide Samson Oluwajoba , Aminat Modupe Ibrahim , Shahzaib Ahmad , Aashna Mehta , Osasere Jude-Kelly Osayawe , Damilola Oyebode , Oluwaseun Akinsola , Abraham Osinuga , Isreal Ayobami Onifade , Ibrahim O. Adelakun , Ridwan Olamilekan Adesola , Taiwo Bakare Abidola , Adedeji Daniel Ogunyemi , Oluwaseun Adeolu Ogundijo , Olamilekan Gabriel Banwo , Chibuzo H. Obiechefu
{"title":"Nanomedicine in cancer therapy: Advancing precision treatments","authors":"Abdullahi Tunde Aborode , Ayomide Samson Oluwajoba , Aminat Modupe Ibrahim , Shahzaib Ahmad , Aashna Mehta , Osasere Jude-Kelly Osayawe , Damilola Oyebode , Oluwaseun Akinsola , Abraham Osinuga , Isreal Ayobami Onifade , Ibrahim O. Adelakun , Ridwan Olamilekan Adesola , Taiwo Bakare Abidola , Adedeji Daniel Ogunyemi , Oluwaseun Adeolu Ogundijo , Olamilekan Gabriel Banwo , Chibuzo H. Obiechefu","doi":"10.1016/j.abst.2024.06.003","DOIUrl":null,"url":null,"abstract":"<div><p>The progress made in the field of nanotechnology has resulted in the development of nanomedicine agents, which have demonstrated their efficacy as a promising clinical tool in the fight against different types of cancers. Furthermore, Nanomedicine products possess the potential to achieve intricate targeting strategies and multifunctionality. Currently, nanoparticles possess diverse applications across various scientific disciplines and serve as a crucial component in contemporary medical practices. The specimens have undergone analysis for diverse clinical purposes, including serving as drug carriers, delivering tumor genes, and functioning as contrast compounds in imaging. Diverse nanomaterials derived from organic, inorganic, lipid, or glycan compounds, in addition to synthetic polymers, have been employed to advance and enhance novel cancer therapeutics. The present review centers on the utilization of nanoparticles in clinical settings for the purposes of cancer diagnosis and treatment, with a particular emphasis on their function as drug carriers and targeted therapy agents.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":"6 ","pages":"Pages 105-119"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000103/pdfft?md5=047f325cd4a8218462e22114585218a1&pid=1-s2.0-S2543106424000103-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in biomarker sciences and technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2543106424000103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The progress made in the field of nanotechnology has resulted in the development of nanomedicine agents, which have demonstrated their efficacy as a promising clinical tool in the fight against different types of cancers. Furthermore, Nanomedicine products possess the potential to achieve intricate targeting strategies and multifunctionality. Currently, nanoparticles possess diverse applications across various scientific disciplines and serve as a crucial component in contemporary medical practices. The specimens have undergone analysis for diverse clinical purposes, including serving as drug carriers, delivering tumor genes, and functioning as contrast compounds in imaging. Diverse nanomaterials derived from organic, inorganic, lipid, or glycan compounds, in addition to synthetic polymers, have been employed to advance and enhance novel cancer therapeutics. The present review centers on the utilization of nanoparticles in clinical settings for the purposes of cancer diagnosis and treatment, with a particular emphasis on their function as drug carriers and targeted therapy agents.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
